Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00349570
Other study ID # 90-1027
Secondary ID
Status Completed
Phase N/A
First received July 5, 2006
Last updated October 20, 2008
Start date August 2006
Est. completion date March 2008

Study information

Verified date October 2008
Source Lumen Biomedical
Contact n/a
Is FDA regulated No
Health authority New Zealand: Ministry of Health
Study type Interventional

Clinical Trial Summary

Intra-coronary thrombosis and thromboembolism continues to be a challenge for percutaneous coronary and other vascular interventional techniques. The Xtract™ Aspiration Catheter is a single use device designed to remove fresh, soft emboli and thrombi from the arterial system using standard catheter techniques, compatible with 6 Fr guide catheters and 0.014 guidewires. The purpose of this registry study is to validate the design and demonstrate the performance of the Xtract Aspiration Catheter as a thrombectomy catheter during percutaneous intervention of vessels in the arterial system. Subjects will be enrolled during percutaneous intervention when the Interventional Physician decides a thrombectomy catheter is needed to remove thrombus during the procedure.


Recruitment information / eligibility

Status Completed
Enrollment 0
Est. completion date March 2008
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Planned percutaneous intervention to a native coronary, coronary vein graft, renal artery or carotid artery lesion

- Angiographic evidence of thrombus.

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Fresh Soft Emboli or Thrombi in the Arteries.

Intervention

Device:
Xtract Aspiration Catheter


Locations

Country Name City State
New Zealand Auckland City Hospital Auckland
New Zealand ChristChurch Hospital ChristChurch

Sponsors (1)

Lead Sponsor Collaborator
Lumen Biomedical

Country where clinical trial is conducted

New Zealand, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary objective of the study will be to evaluate the performance of the Xtract Aspiration Catheter.